Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/nppa-to-intensify-drug-price-verification-17960/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/nppa-to-intensify-drug-price-verification-17960/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/nppa-to-intensify-drug-price-verification-17960/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/nppa-to-intensify-drug-price-verification-17960/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680141133e06e-trace').style.display = (document.getElementById('cakeErr680141133e06e-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr680141133e06e-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680141133e06e-code').style.display = (document.getElementById('cakeErr680141133e06e-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr680141133e06e-context').style.display = (document.getElementById('cakeErr680141133e06e-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr680141133e06e-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr680141133e06e-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 17831,
		&#039;title&#039; =&gt; &#039;NPPA to intensify drug price verification&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Business Standard
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&amp;nbsp;&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) has issued internal guidelines putting in place norms for verification of actual cost data, provided by companies, through plant visits. &amp;nbsp;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;ldquo;Plant visits to be made for verification of data and collection of additional data, understanding product, process etc, and holding discussions with the officials of the company,&amp;rdquo; the guideline notification said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
As per the norms, the NPPA will look into various aspects such as maintenance of manufacturing unit and machinery, capacity utilization and assessment and research and development activities.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
NPPA, which directly controls prices of 74 bulk drugs and formulations containing one or more of these bulk drugs, currently fixes prices of such products based on a cost-plus formula. The regulator seeks actual cost data from companies and gathers information from other sources to calculate the best price.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;ldquo;There are often clashes between data sent by companies and what we gather through other sources. The interpretation of data could also vary. We often arbitrarily accept whatever is lower. So, the effort is to maintain uniformity in approach and avoid subjectivity in interpretation,&amp;rdquo; a senior NPPA official said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Another senior official said, many a times it is found that the cost on capacity enhancement and R&amp;amp;D shown by companies is not valid. &amp;ldquo;There are &amp;nbsp;cases where the company is not using its capacity to the fullest and is increasing cost on maintenance etc. We want to corroborate such information by visiting units, understanding the processes and engaging into discussions with companies,&amp;rdquo; one of the officials said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
While determining prices of products, NPPA would look into technical parameters such as yields, capacity assessment and utilization, maintenance of plant and machinery, cost of raw material, research and development &amp;nbsp;and expansion of manufacturing plants and replacement of machinery.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
In case if a particular unit is manufacturing 90% or more of the total production in the country, the regulator will not visit any other facility to study the same data unless the cost of production at the other facility is lower than that of the major producer, the guidelines said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
However, there are no provisions for penalty for a company submitting wrong details to the regulator. &amp;ldquo;The idea is to monitor and not to punish. The company may not give us wrong information, it is because their interpretation of a data could be different from what we draw out of it. Therefore, refinement of the existing system is necessary,&amp;rdquo; the official said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Experts, however, say that if diligently practiced by the regulator, this may leave little room for drug makers to dodge the system.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Business Standard, 5 November, 2012, http://www.business-standard.com/india/news/exclusive-nppa-to-intensify-drug-price-verification/194444/on&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;nppa-to-intensify-drug-price-verification-17960&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 17960,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 17831,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | NPPA to intensify drug price verification&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health,Inflation&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Business Standard





The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&amp;nbsp;





The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Business Standard&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&amp;nbsp;&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) has issued internal guidelines putting in place norms for verification of actual cost data, provided by companies, through plant visits. &amp;nbsp;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;ldquo;Plant visits to be made for verification of data and collection of additional data, understanding product, process etc, and holding discussions with the officials of the company,&amp;rdquo; the guideline notification said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;As per the norms, the NPPA will look into various aspects such as maintenance of manufacturing unit and machinery, capacity utilization and assessment and research and development activities.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;NPPA, which directly controls prices of 74 bulk drugs and formulations containing one or more of these bulk drugs, currently fixes prices of such products based on a cost-plus formula. The regulator seeks actual cost data from companies and gathers information from other sources to calculate the best price.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;ldquo;There are often clashes between data sent by companies and what we gather through other sources. The interpretation of data could also vary. We often arbitrarily accept whatever is lower. So, the effort is to maintain uniformity in approach and avoid subjectivity in interpretation,&amp;rdquo; a senior NPPA official said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Another senior official said, many a times it is found that the cost on capacity enhancement and R&amp;amp;D shown by companies is not valid. &amp;ldquo;There are &amp;nbsp;cases where the company is not using its capacity to the fullest and is increasing cost on maintenance etc. We want to corroborate such information by visiting units, understanding the processes and engaging into discussions with companies,&amp;rdquo; one of the officials said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;While determining prices of products, NPPA would look into technical parameters such as yields, capacity assessment and utilization, maintenance of plant and machinery, cost of raw material, research and development &amp;nbsp;and expansion of manufacturing plants and replacement of machinery.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;In case if a particular unit is manufacturing 90% or more of the total production in the country, the regulator will not visit any other facility to study the same data unless the cost of production at the other facility is lower than that of the major producer, the guidelines said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;However, there are no provisions for penalty for a company submitting wrong details to the regulator. &amp;ldquo;The idea is to monitor and not to punish. The company may not give us wrong information, it is because their interpretation of a data could be different from what we draw out of it. Therefore, refinement of the existing system is necessary,&amp;rdquo; the official said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Experts, however, say that if diligently practiced by the regulator, this may leave little room for drug makers to dodge the system.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 17831,
	&#039;title&#039; =&gt; &#039;NPPA to intensify drug price verification&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Business Standard
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&amp;nbsp;&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) has issued internal guidelines putting in place norms for verification of actual cost data, provided by companies, through plant visits. &amp;nbsp;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;ldquo;Plant visits to be made for verification of data and collection of additional data, understanding product, process etc, and holding discussions with the officials of the company,&amp;rdquo; the guideline notification said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
As per the norms, the NPPA will look into various aspects such as maintenance of manufacturing unit and machinery, capacity utilization and assessment and research and development activities.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
NPPA, which directly controls prices of 74 bulk drugs and formulations containing one or more of these bulk drugs, currently fixes prices of such products based on a cost-plus formula. The regulator seeks actual cost data from companies and gathers information from other sources to calculate the best price.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;ldquo;There are often clashes between data sent by companies and what we gather through other sources. The interpretation of data could also vary. We often arbitrarily accept whatever is lower. So, the effort is to maintain uniformity in approach and avoid subjectivity in interpretation,&amp;rdquo; a senior NPPA official said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Another senior official said, many a times it is found that the cost on capacity enhancement and R&amp;amp;D shown by companies is not valid. &amp;ldquo;There are &amp;nbsp;cases where the company is not using its capacity to the fullest and is increasing cost on maintenance etc. We want to corroborate such information by visiting units, understanding the processes and engaging into discussions with companies,&amp;rdquo; one of the officials said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
While determining prices of products, NPPA would look into technical parameters such as yields, capacity assessment and utilization, maintenance of plant and machinery, cost of raw material, research and development &amp;nbsp;and expansion of manufacturing plants and replacement of machinery.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
In case if a particular unit is manufacturing 90% or more of the total production in the country, the regulator will not visit any other facility to study the same data unless the cost of production at the other facility is lower than that of the major producer, the guidelines said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
However, there are no provisions for penalty for a company submitting wrong details to the regulator. &amp;ldquo;The idea is to monitor and not to punish. The company may not give us wrong information, it is because their interpretation of a data could be different from what we draw out of it. Therefore, refinement of the existing system is necessary,&amp;rdquo; the official said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Experts, however, say that if diligently practiced by the regulator, this may leave little room for drug makers to dodge the system.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Business Standard, 5 November, 2012, http://www.business-standard.com/india/news/exclusive-nppa-to-intensify-drug-price-verification/194444/on&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;nppa-to-intensify-drug-price-verification-17960&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 17960,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 17831
$metaTitle = &#039;LATEST NEWS UPDATES | NPPA to intensify drug price verification&#039;
$metaKeywords = &#039;medicines,Health,Inflation&#039;
$metaDesc = &#039;
-The Business Standard





The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&amp;nbsp;





The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The...&#039;
$disp = &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Business Standard&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&amp;nbsp;&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) has issued internal guidelines putting in place norms for verification of actual cost data, provided by companies, through plant visits. &amp;nbsp;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;ldquo;Plant visits to be made for verification of data and collection of additional data, understanding product, process etc, and holding discussions with the officials of the company,&amp;rdquo; the guideline notification said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;As per the norms, the NPPA will look into various aspects such as maintenance of manufacturing unit and machinery, capacity utilization and assessment and research and development activities.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;NPPA, which directly controls prices of 74 bulk drugs and formulations containing one or more of these bulk drugs, currently fixes prices of such products based on a cost-plus formula. The regulator seeks actual cost data from companies and gathers information from other sources to calculate the best price.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;ldquo;There are often clashes between data sent by companies and what we gather through other sources. The interpretation of data could also vary. We often arbitrarily accept whatever is lower. So, the effort is to maintain uniformity in approach and avoid subjectivity in interpretation,&amp;rdquo; a senior NPPA official said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Another senior official said, many a times it is found that the cost on capacity enhancement and R&amp;amp;D shown by companies is not valid. &amp;ldquo;There are &amp;nbsp;cases where the company is not using its capacity to the fullest and is increasing cost on maintenance etc. We want to corroborate such information by visiting units, understanding the processes and engaging into discussions with companies,&amp;rdquo; one of the officials said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;While determining prices of products, NPPA would look into technical parameters such as yields, capacity assessment and utilization, maintenance of plant and machinery, cost of raw material, research and development &amp;nbsp;and expansion of manufacturing plants and replacement of machinery.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;In case if a particular unit is manufacturing 90% or more of the total production in the country, the regulator will not visit any other facility to study the same data unless the cost of production at the other facility is lower than that of the major producer, the guidelines said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;However, there are no provisions for penalty for a company submitting wrong details to the regulator. &amp;ldquo;The idea is to monitor and not to punish. The company may not give us wrong information, it is because their interpretation of a data could be different from what we draw out of it. Therefore, refinement of the existing system is necessary,&amp;rdquo; the official said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Experts, however, say that if diligently practiced by the regulator, this may leave little room for drug makers to dodge the system.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/nppa-to-intensify-drug-price-verification-17960.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | NPPA to intensify drug price verification | Im4change.org</title>
    <meta name="description" content="
-The Business Standard





The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&nbsp;





The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>NPPA to intensify drug price verification</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div style="text-align: justify">-The Business Standard</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&nbsp;</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) has issued internal guidelines putting in place norms for verification of actual cost data, provided by companies, through plant visits. &nbsp;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&ldquo;Plant visits to be made for verification of data and collection of additional data, understanding product, process etc, and holding discussions with the officials of the company,&rdquo; the guideline notification said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">As per the norms, the NPPA will look into various aspects such as maintenance of manufacturing unit and machinery, capacity utilization and assessment and research and development activities.</div><div style="text-align: justify">NPPA, which directly controls prices of 74 bulk drugs and formulations containing one or more of these bulk drugs, currently fixes prices of such products based on a cost-plus formula. The regulator seeks actual cost data from companies and gathers information from other sources to calculate the best price.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&ldquo;There are often clashes between data sent by companies and what we gather through other sources. The interpretation of data could also vary. We often arbitrarily accept whatever is lower. So, the effort is to maintain uniformity in approach and avoid subjectivity in interpretation,&rdquo; a senior NPPA official said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Another senior official said, many a times it is found that the cost on capacity enhancement and R&amp;D shown by companies is not valid. &ldquo;There are &nbsp;cases where the company is not using its capacity to the fullest and is increasing cost on maintenance etc. We want to corroborate such information by visiting units, understanding the processes and engaging into discussions with companies,&rdquo; one of the officials said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">While determining prices of products, NPPA would look into technical parameters such as yields, capacity assessment and utilization, maintenance of plant and machinery, cost of raw material, research and development &nbsp;and expansion of manufacturing plants and replacement of machinery.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">In case if a particular unit is manufacturing 90% or more of the total production in the country, the regulator will not visit any other facility to study the same data unless the cost of production at the other facility is lower than that of the major producer, the guidelines said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">However, there are no provisions for penalty for a company submitting wrong details to the regulator. &ldquo;The idea is to monitor and not to punish. The company may not give us wrong information, it is because their interpretation of a data could be different from what we draw out of it. Therefore, refinement of the existing system is necessary,&rdquo; the official said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Experts, however, say that if diligently practiced by the regulator, this may leave little room for drug makers to dodge the system.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680141133e06e-trace').style.display = (document.getElementById('cakeErr680141133e06e-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr680141133e06e-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680141133e06e-code').style.display = (document.getElementById('cakeErr680141133e06e-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr680141133e06e-context').style.display = (document.getElementById('cakeErr680141133e06e-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr680141133e06e-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr680141133e06e-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 17831,
		&#039;title&#039; =&gt; &#039;NPPA to intensify drug price verification&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Business Standard
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&amp;nbsp;&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) has issued internal guidelines putting in place norms for verification of actual cost data, provided by companies, through plant visits. &amp;nbsp;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;ldquo;Plant visits to be made for verification of data and collection of additional data, understanding product, process etc, and holding discussions with the officials of the company,&amp;rdquo; the guideline notification said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
As per the norms, the NPPA will look into various aspects such as maintenance of manufacturing unit and machinery, capacity utilization and assessment and research and development activities.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
NPPA, which directly controls prices of 74 bulk drugs and formulations containing one or more of these bulk drugs, currently fixes prices of such products based on a cost-plus formula. The regulator seeks actual cost data from companies and gathers information from other sources to calculate the best price.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;ldquo;There are often clashes between data sent by companies and what we gather through other sources. The interpretation of data could also vary. We often arbitrarily accept whatever is lower. So, the effort is to maintain uniformity in approach and avoid subjectivity in interpretation,&amp;rdquo; a senior NPPA official said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Another senior official said, many a times it is found that the cost on capacity enhancement and R&amp;amp;D shown by companies is not valid. &amp;ldquo;There are &amp;nbsp;cases where the company is not using its capacity to the fullest and is increasing cost on maintenance etc. We want to corroborate such information by visiting units, understanding the processes and engaging into discussions with companies,&amp;rdquo; one of the officials said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
While determining prices of products, NPPA would look into technical parameters such as yields, capacity assessment and utilization, maintenance of plant and machinery, cost of raw material, research and development &amp;nbsp;and expansion of manufacturing plants and replacement of machinery.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
In case if a particular unit is manufacturing 90% or more of the total production in the country, the regulator will not visit any other facility to study the same data unless the cost of production at the other facility is lower than that of the major producer, the guidelines said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
However, there are no provisions for penalty for a company submitting wrong details to the regulator. &amp;ldquo;The idea is to monitor and not to punish. The company may not give us wrong information, it is because their interpretation of a data could be different from what we draw out of it. Therefore, refinement of the existing system is necessary,&amp;rdquo; the official said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Experts, however, say that if diligently practiced by the regulator, this may leave little room for drug makers to dodge the system.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Business Standard, 5 November, 2012, http://www.business-standard.com/india/news/exclusive-nppa-to-intensify-drug-price-verification/194444/on&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;nppa-to-intensify-drug-price-verification-17960&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 17960,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 17831,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | NPPA to intensify drug price verification&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health,Inflation&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Business Standard





The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&amp;nbsp;





The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Business Standard&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&amp;nbsp;&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) has issued internal guidelines putting in place norms for verification of actual cost data, provided by companies, through plant visits. &amp;nbsp;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;ldquo;Plant visits to be made for verification of data and collection of additional data, understanding product, process etc, and holding discussions with the officials of the company,&amp;rdquo; the guideline notification said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;As per the norms, the NPPA will look into various aspects such as maintenance of manufacturing unit and machinery, capacity utilization and assessment and research and development activities.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;NPPA, which directly controls prices of 74 bulk drugs and formulations containing one or more of these bulk drugs, currently fixes prices of such products based on a cost-plus formula. The regulator seeks actual cost data from companies and gathers information from other sources to calculate the best price.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;ldquo;There are often clashes between data sent by companies and what we gather through other sources. The interpretation of data could also vary. We often arbitrarily accept whatever is lower. So, the effort is to maintain uniformity in approach and avoid subjectivity in interpretation,&amp;rdquo; a senior NPPA official said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Another senior official said, many a times it is found that the cost on capacity enhancement and R&amp;amp;D shown by companies is not valid. &amp;ldquo;There are &amp;nbsp;cases where the company is not using its capacity to the fullest and is increasing cost on maintenance etc. We want to corroborate such information by visiting units, understanding the processes and engaging into discussions with companies,&amp;rdquo; one of the officials said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;While determining prices of products, NPPA would look into technical parameters such as yields, capacity assessment and utilization, maintenance of plant and machinery, cost of raw material, research and development &amp;nbsp;and expansion of manufacturing plants and replacement of machinery.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;In case if a particular unit is manufacturing 90% or more of the total production in the country, the regulator will not visit any other facility to study the same data unless the cost of production at the other facility is lower than that of the major producer, the guidelines said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;However, there are no provisions for penalty for a company submitting wrong details to the regulator. &amp;ldquo;The idea is to monitor and not to punish. The company may not give us wrong information, it is because their interpretation of a data could be different from what we draw out of it. Therefore, refinement of the existing system is necessary,&amp;rdquo; the official said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Experts, however, say that if diligently practiced by the regulator, this may leave little room for drug makers to dodge the system.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 17831,
	&#039;title&#039; =&gt; &#039;NPPA to intensify drug price verification&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Business Standard
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&amp;nbsp;&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) has issued internal guidelines putting in place norms for verification of actual cost data, provided by companies, through plant visits. &amp;nbsp;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;ldquo;Plant visits to be made for verification of data and collection of additional data, understanding product, process etc, and holding discussions with the officials of the company,&amp;rdquo; the guideline notification said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
As per the norms, the NPPA will look into various aspects such as maintenance of manufacturing unit and machinery, capacity utilization and assessment and research and development activities.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
NPPA, which directly controls prices of 74 bulk drugs and formulations containing one or more of these bulk drugs, currently fixes prices of such products based on a cost-plus formula. The regulator seeks actual cost data from companies and gathers information from other sources to calculate the best price.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;ldquo;There are often clashes between data sent by companies and what we gather through other sources. The interpretation of data could also vary. We often arbitrarily accept whatever is lower. So, the effort is to maintain uniformity in approach and avoid subjectivity in interpretation,&amp;rdquo; a senior NPPA official said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Another senior official said, many a times it is found that the cost on capacity enhancement and R&amp;amp;D shown by companies is not valid. &amp;ldquo;There are &amp;nbsp;cases where the company is not using its capacity to the fullest and is increasing cost on maintenance etc. We want to corroborate such information by visiting units, understanding the processes and engaging into discussions with companies,&amp;rdquo; one of the officials said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
While determining prices of products, NPPA would look into technical parameters such as yields, capacity assessment and utilization, maintenance of plant and machinery, cost of raw material, research and development &amp;nbsp;and expansion of manufacturing plants and replacement of machinery.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
In case if a particular unit is manufacturing 90% or more of the total production in the country, the regulator will not visit any other facility to study the same data unless the cost of production at the other facility is lower than that of the major producer, the guidelines said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
However, there are no provisions for penalty for a company submitting wrong details to the regulator. &amp;ldquo;The idea is to monitor and not to punish. The company may not give us wrong information, it is because their interpretation of a data could be different from what we draw out of it. Therefore, refinement of the existing system is necessary,&amp;rdquo; the official said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Experts, however, say that if diligently practiced by the regulator, this may leave little room for drug makers to dodge the system.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Business Standard, 5 November, 2012, http://www.business-standard.com/india/news/exclusive-nppa-to-intensify-drug-price-verification/194444/on&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;nppa-to-intensify-drug-price-verification-17960&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 17960,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 17831
$metaTitle = &#039;LATEST NEWS UPDATES | NPPA to intensify drug price verification&#039;
$metaKeywords = &#039;medicines,Health,Inflation&#039;
$metaDesc = &#039;
-The Business Standard





The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&amp;nbsp;





The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The...&#039;
$disp = &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Business Standard&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&amp;nbsp;&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) has issued internal guidelines putting in place norms for verification of actual cost data, provided by companies, through plant visits. &amp;nbsp;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;ldquo;Plant visits to be made for verification of data and collection of additional data, understanding product, process etc, and holding discussions with the officials of the company,&amp;rdquo; the guideline notification said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;As per the norms, the NPPA will look into various aspects such as maintenance of manufacturing unit and machinery, capacity utilization and assessment and research and development activities.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;NPPA, which directly controls prices of 74 bulk drugs and formulations containing one or more of these bulk drugs, currently fixes prices of such products based on a cost-plus formula. The regulator seeks actual cost data from companies and gathers information from other sources to calculate the best price.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;ldquo;There are often clashes between data sent by companies and what we gather through other sources. The interpretation of data could also vary. We often arbitrarily accept whatever is lower. So, the effort is to maintain uniformity in approach and avoid subjectivity in interpretation,&amp;rdquo; a senior NPPA official said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Another senior official said, many a times it is found that the cost on capacity enhancement and R&amp;amp;D shown by companies is not valid. &amp;ldquo;There are &amp;nbsp;cases where the company is not using its capacity to the fullest and is increasing cost on maintenance etc. We want to corroborate such information by visiting units, understanding the processes and engaging into discussions with companies,&amp;rdquo; one of the officials said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;While determining prices of products, NPPA would look into technical parameters such as yields, capacity assessment and utilization, maintenance of plant and machinery, cost of raw material, research and development &amp;nbsp;and expansion of manufacturing plants and replacement of machinery.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;In case if a particular unit is manufacturing 90% or more of the total production in the country, the regulator will not visit any other facility to study the same data unless the cost of production at the other facility is lower than that of the major producer, the guidelines said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;However, there are no provisions for penalty for a company submitting wrong details to the regulator. &amp;ldquo;The idea is to monitor and not to punish. The company may not give us wrong information, it is because their interpretation of a data could be different from what we draw out of it. Therefore, refinement of the existing system is necessary,&amp;rdquo; the official said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Experts, however, say that if diligently practiced by the regulator, this may leave little room for drug makers to dodge the system.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/nppa-to-intensify-drug-price-verification-17960.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | NPPA to intensify drug price verification | Im4change.org</title>
    <meta name="description" content="
-The Business Standard





The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&nbsp;





The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>NPPA to intensify drug price verification</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div style="text-align: justify">-The Business Standard</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&nbsp;</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) has issued internal guidelines putting in place norms for verification of actual cost data, provided by companies, through plant visits. &nbsp;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&ldquo;Plant visits to be made for verification of data and collection of additional data, understanding product, process etc, and holding discussions with the officials of the company,&rdquo; the guideline notification said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">As per the norms, the NPPA will look into various aspects such as maintenance of manufacturing unit and machinery, capacity utilization and assessment and research and development activities.</div><div style="text-align: justify">NPPA, which directly controls prices of 74 bulk drugs and formulations containing one or more of these bulk drugs, currently fixes prices of such products based on a cost-plus formula. The regulator seeks actual cost data from companies and gathers information from other sources to calculate the best price.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&ldquo;There are often clashes between data sent by companies and what we gather through other sources. The interpretation of data could also vary. We often arbitrarily accept whatever is lower. So, the effort is to maintain uniformity in approach and avoid subjectivity in interpretation,&rdquo; a senior NPPA official said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Another senior official said, many a times it is found that the cost on capacity enhancement and R&amp;D shown by companies is not valid. &ldquo;There are &nbsp;cases where the company is not using its capacity to the fullest and is increasing cost on maintenance etc. We want to corroborate such information by visiting units, understanding the processes and engaging into discussions with companies,&rdquo; one of the officials said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">While determining prices of products, NPPA would look into technical parameters such as yields, capacity assessment and utilization, maintenance of plant and machinery, cost of raw material, research and development &nbsp;and expansion of manufacturing plants and replacement of machinery.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">In case if a particular unit is manufacturing 90% or more of the total production in the country, the regulator will not visit any other facility to study the same data unless the cost of production at the other facility is lower than that of the major producer, the guidelines said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">However, there are no provisions for penalty for a company submitting wrong details to the regulator. &ldquo;The idea is to monitor and not to punish. The company may not give us wrong information, it is because their interpretation of a data could be different from what we draw out of it. Therefore, refinement of the existing system is necessary,&rdquo; the official said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Experts, however, say that if diligently practiced by the regulator, this may leave little room for drug makers to dodge the system.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680141133e06e-trace').style.display = (document.getElementById('cakeErr680141133e06e-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr680141133e06e-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr680141133e06e-code').style.display = (document.getElementById('cakeErr680141133e06e-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr680141133e06e-context').style.display = (document.getElementById('cakeErr680141133e06e-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr680141133e06e-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr680141133e06e-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 17831,
		&#039;title&#039; =&gt; &#039;NPPA to intensify drug price verification&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Business Standard
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&amp;nbsp;&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) has issued internal guidelines putting in place norms for verification of actual cost data, provided by companies, through plant visits. &amp;nbsp;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;ldquo;Plant visits to be made for verification of data and collection of additional data, understanding product, process etc, and holding discussions with the officials of the company,&amp;rdquo; the guideline notification said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
As per the norms, the NPPA will look into various aspects such as maintenance of manufacturing unit and machinery, capacity utilization and assessment and research and development activities.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
NPPA, which directly controls prices of 74 bulk drugs and formulations containing one or more of these bulk drugs, currently fixes prices of such products based on a cost-plus formula. The regulator seeks actual cost data from companies and gathers information from other sources to calculate the best price.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;ldquo;There are often clashes between data sent by companies and what we gather through other sources. The interpretation of data could also vary. We often arbitrarily accept whatever is lower. So, the effort is to maintain uniformity in approach and avoid subjectivity in interpretation,&amp;rdquo; a senior NPPA official said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Another senior official said, many a times it is found that the cost on capacity enhancement and R&amp;amp;D shown by companies is not valid. &amp;ldquo;There are &amp;nbsp;cases where the company is not using its capacity to the fullest and is increasing cost on maintenance etc. We want to corroborate such information by visiting units, understanding the processes and engaging into discussions with companies,&amp;rdquo; one of the officials said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
While determining prices of products, NPPA would look into technical parameters such as yields, capacity assessment and utilization, maintenance of plant and machinery, cost of raw material, research and development &amp;nbsp;and expansion of manufacturing plants and replacement of machinery.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
In case if a particular unit is manufacturing 90% or more of the total production in the country, the regulator will not visit any other facility to study the same data unless the cost of production at the other facility is lower than that of the major producer, the guidelines said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
However, there are no provisions for penalty for a company submitting wrong details to the regulator. &amp;ldquo;The idea is to monitor and not to punish. The company may not give us wrong information, it is because their interpretation of a data could be different from what we draw out of it. Therefore, refinement of the existing system is necessary,&amp;rdquo; the official said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Experts, however, say that if diligently practiced by the regulator, this may leave little room for drug makers to dodge the system.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Business Standard, 5 November, 2012, http://www.business-standard.com/india/news/exclusive-nppa-to-intensify-drug-price-verification/194444/on&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;nppa-to-intensify-drug-price-verification-17960&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 17960,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 17831,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | NPPA to intensify drug price verification&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health,Inflation&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Business Standard





The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&amp;nbsp;





The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Business Standard&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&amp;nbsp;&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) has issued internal guidelines putting in place norms for verification of actual cost data, provided by companies, through plant visits. &amp;nbsp;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;ldquo;Plant visits to be made for verification of data and collection of additional data, understanding product, process etc, and holding discussions with the officials of the company,&amp;rdquo; the guideline notification said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;As per the norms, the NPPA will look into various aspects such as maintenance of manufacturing unit and machinery, capacity utilization and assessment and research and development activities.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;NPPA, which directly controls prices of 74 bulk drugs and formulations containing one or more of these bulk drugs, currently fixes prices of such products based on a cost-plus formula. The regulator seeks actual cost data from companies and gathers information from other sources to calculate the best price.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;ldquo;There are often clashes between data sent by companies and what we gather through other sources. The interpretation of data could also vary. We often arbitrarily accept whatever is lower. So, the effort is to maintain uniformity in approach and avoid subjectivity in interpretation,&amp;rdquo; a senior NPPA official said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Another senior official said, many a times it is found that the cost on capacity enhancement and R&amp;amp;D shown by companies is not valid. &amp;ldquo;There are &amp;nbsp;cases where the company is not using its capacity to the fullest and is increasing cost on maintenance etc. We want to corroborate such information by visiting units, understanding the processes and engaging into discussions with companies,&amp;rdquo; one of the officials said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;While determining prices of products, NPPA would look into technical parameters such as yields, capacity assessment and utilization, maintenance of plant and machinery, cost of raw material, research and development &amp;nbsp;and expansion of manufacturing plants and replacement of machinery.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;In case if a particular unit is manufacturing 90% or more of the total production in the country, the regulator will not visit any other facility to study the same data unless the cost of production at the other facility is lower than that of the major producer, the guidelines said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;However, there are no provisions for penalty for a company submitting wrong details to the regulator. &amp;ldquo;The idea is to monitor and not to punish. The company may not give us wrong information, it is because their interpretation of a data could be different from what we draw out of it. Therefore, refinement of the existing system is necessary,&amp;rdquo; the official said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Experts, however, say that if diligently practiced by the regulator, this may leave little room for drug makers to dodge the system.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 17831,
	&#039;title&#039; =&gt; &#039;NPPA to intensify drug price verification&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Business Standard
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&amp;nbsp;&lt;/em&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) has issued internal guidelines putting in place norms for verification of actual cost data, provided by companies, through plant visits. &amp;nbsp;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;ldquo;Plant visits to be made for verification of data and collection of additional data, understanding product, process etc, and holding discussions with the officials of the company,&amp;rdquo; the guideline notification said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
As per the norms, the NPPA will look into various aspects such as maintenance of manufacturing unit and machinery, capacity utilization and assessment and research and development activities.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
NPPA, which directly controls prices of 74 bulk drugs and formulations containing one or more of these bulk drugs, currently fixes prices of such products based on a cost-plus formula. The regulator seeks actual cost data from companies and gathers information from other sources to calculate the best price.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&amp;ldquo;There are often clashes between data sent by companies and what we gather through other sources. The interpretation of data could also vary. We often arbitrarily accept whatever is lower. So, the effort is to maintain uniformity in approach and avoid subjectivity in interpretation,&amp;rdquo; a senior NPPA official said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Another senior official said, many a times it is found that the cost on capacity enhancement and R&amp;amp;D shown by companies is not valid. &amp;ldquo;There are &amp;nbsp;cases where the company is not using its capacity to the fullest and is increasing cost on maintenance etc. We want to corroborate such information by visiting units, understanding the processes and engaging into discussions with companies,&amp;rdquo; one of the officials said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
While determining prices of products, NPPA would look into technical parameters such as yields, capacity assessment and utilization, maintenance of plant and machinery, cost of raw material, research and development &amp;nbsp;and expansion of manufacturing plants and replacement of machinery.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
In case if a particular unit is manufacturing 90% or more of the total production in the country, the regulator will not visit any other facility to study the same data unless the cost of production at the other facility is lower than that of the major producer, the guidelines said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
However, there are no provisions for penalty for a company submitting wrong details to the regulator. &amp;ldquo;The idea is to monitor and not to punish. The company may not give us wrong information, it is because their interpretation of a data could be different from what we draw out of it. Therefore, refinement of the existing system is necessary,&amp;rdquo; the official said.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Experts, however, say that if diligently practiced by the regulator, this may leave little room for drug makers to dodge the system.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Business Standard, 5 November, 2012, http://www.business-standard.com/india/news/exclusive-nppa-to-intensify-drug-price-verification/194444/on&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;nppa-to-intensify-drug-price-verification-17960&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 17960,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 17831
$metaTitle = &#039;LATEST NEWS UPDATES | NPPA to intensify drug price verification&#039;
$metaKeywords = &#039;medicines,Health,Inflation&#039;
$metaDesc = &#039;
-The Business Standard





The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&amp;nbsp;





The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The...&#039;
$disp = &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Business Standard&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;em&gt;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&amp;nbsp;&lt;/em&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) has issued internal guidelines putting in place norms for verification of actual cost data, provided by companies, through plant visits. &amp;nbsp;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;ldquo;Plant visits to be made for verification of data and collection of additional data, understanding product, process etc, and holding discussions with the officials of the company,&amp;rdquo; the guideline notification said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;As per the norms, the NPPA will look into various aspects such as maintenance of manufacturing unit and machinery, capacity utilization and assessment and research and development activities.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;NPPA, which directly controls prices of 74 bulk drugs and formulations containing one or more of these bulk drugs, currently fixes prices of such products based on a cost-plus formula. The regulator seeks actual cost data from companies and gathers information from other sources to calculate the best price.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&amp;ldquo;There are often clashes between data sent by companies and what we gather through other sources. The interpretation of data could also vary. We often arbitrarily accept whatever is lower. So, the effort is to maintain uniformity in approach and avoid subjectivity in interpretation,&amp;rdquo; a senior NPPA official said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Another senior official said, many a times it is found that the cost on capacity enhancement and R&amp;amp;D shown by companies is not valid. &amp;ldquo;There are &amp;nbsp;cases where the company is not using its capacity to the fullest and is increasing cost on maintenance etc. We want to corroborate such information by visiting units, understanding the processes and engaging into discussions with companies,&amp;rdquo; one of the officials said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;While determining prices of products, NPPA would look into technical parameters such as yields, capacity assessment and utilization, maintenance of plant and machinery, cost of raw material, research and development &amp;nbsp;and expansion of manufacturing plants and replacement of machinery.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;In case if a particular unit is manufacturing 90% or more of the total production in the country, the regulator will not visit any other facility to study the same data unless the cost of production at the other facility is lower than that of the major producer, the guidelines said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;However, there are no provisions for penalty for a company submitting wrong details to the regulator. &amp;ldquo;The idea is to monitor and not to punish. The company may not give us wrong information, it is because their interpretation of a data could be different from what we draw out of it. Therefore, refinement of the existing system is necessary,&amp;rdquo; the official said.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Experts, however, say that if diligently practiced by the regulator, this may leave little room for drug makers to dodge the system.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/nppa-to-intensify-drug-price-verification-17960.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | NPPA to intensify drug price verification | Im4change.org</title>
    <meta name="description" content="
-The Business Standard





The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&nbsp;





The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>NPPA to intensify drug price verification</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div style="text-align: justify">-The Business Standard</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&nbsp;</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) has issued internal guidelines putting in place norms for verification of actual cost data, provided by companies, through plant visits. &nbsp;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&ldquo;Plant visits to be made for verification of data and collection of additional data, understanding product, process etc, and holding discussions with the officials of the company,&rdquo; the guideline notification said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">As per the norms, the NPPA will look into various aspects such as maintenance of manufacturing unit and machinery, capacity utilization and assessment and research and development activities.</div><div style="text-align: justify">NPPA, which directly controls prices of 74 bulk drugs and formulations containing one or more of these bulk drugs, currently fixes prices of such products based on a cost-plus formula. The regulator seeks actual cost data from companies and gathers information from other sources to calculate the best price.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&ldquo;There are often clashes between data sent by companies and what we gather through other sources. The interpretation of data could also vary. We often arbitrarily accept whatever is lower. So, the effort is to maintain uniformity in approach and avoid subjectivity in interpretation,&rdquo; a senior NPPA official said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Another senior official said, many a times it is found that the cost on capacity enhancement and R&amp;D shown by companies is not valid. &ldquo;There are &nbsp;cases where the company is not using its capacity to the fullest and is increasing cost on maintenance etc. We want to corroborate such information by visiting units, understanding the processes and engaging into discussions with companies,&rdquo; one of the officials said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">While determining prices of products, NPPA would look into technical parameters such as yields, capacity assessment and utilization, maintenance of plant and machinery, cost of raw material, research and development &nbsp;and expansion of manufacturing plants and replacement of machinery.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">In case if a particular unit is manufacturing 90% or more of the total production in the country, the regulator will not visit any other facility to study the same data unless the cost of production at the other facility is lower than that of the major producer, the guidelines said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">However, there are no provisions for penalty for a company submitting wrong details to the regulator. &ldquo;The idea is to monitor and not to punish. The company may not give us wrong information, it is because their interpretation of a data could be different from what we draw out of it. Therefore, refinement of the existing system is necessary,&rdquo; the official said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Experts, however, say that if diligently practiced by the regulator, this may leave little room for drug makers to dodge the system.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 17831,
		'title' => 'NPPA to intensify drug price verification',
		'subheading' => '',
		'description' => '<div style="text-align: justify">
-The Business Standard
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
<em>The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&nbsp;</em>
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) has issued internal guidelines putting in place norms for verification of actual cost data, provided by companies, through plant visits. &nbsp;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
&ldquo;Plant visits to be made for verification of data and collection of additional data, understanding product, process etc, and holding discussions with the officials of the company,&rdquo; the guideline notification said.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
As per the norms, the NPPA will look into various aspects such as maintenance of manufacturing unit and machinery, capacity utilization and assessment and research and development activities.
</div>
<div style="text-align: justify">
NPPA, which directly controls prices of 74 bulk drugs and formulations containing one or more of these bulk drugs, currently fixes prices of such products based on a cost-plus formula. The regulator seeks actual cost data from companies and gathers information from other sources to calculate the best price.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
&ldquo;There are often clashes between data sent by companies and what we gather through other sources. The interpretation of data could also vary. We often arbitrarily accept whatever is lower. So, the effort is to maintain uniformity in approach and avoid subjectivity in interpretation,&rdquo; a senior NPPA official said.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
Another senior official said, many a times it is found that the cost on capacity enhancement and R&amp;D shown by companies is not valid. &ldquo;There are &nbsp;cases where the company is not using its capacity to the fullest and is increasing cost on maintenance etc. We want to corroborate such information by visiting units, understanding the processes and engaging into discussions with companies,&rdquo; one of the officials said.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
While determining prices of products, NPPA would look into technical parameters such as yields, capacity assessment and utilization, maintenance of plant and machinery, cost of raw material, research and development &nbsp;and expansion of manufacturing plants and replacement of machinery.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
In case if a particular unit is manufacturing 90% or more of the total production in the country, the regulator will not visit any other facility to study the same data unless the cost of production at the other facility is lower than that of the major producer, the guidelines said.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
However, there are no provisions for penalty for a company submitting wrong details to the regulator. &ldquo;The idea is to monitor and not to punish. The company may not give us wrong information, it is because their interpretation of a data could be different from what we draw out of it. Therefore, refinement of the existing system is necessary,&rdquo; the official said.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
Experts, however, say that if diligently practiced by the regulator, this may leave little room for drug makers to dodge the system.
</div>',
		'credit_writer' => 'The Business Standard, 5 November, 2012, http://www.business-standard.com/india/news/exclusive-nppa-to-intensify-drug-price-verification/194444/on',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'nppa-to-intensify-drug-price-verification-17960',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 17960,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 17831,
	'metaTitle' => 'LATEST NEWS UPDATES | NPPA to intensify drug price verification',
	'metaKeywords' => 'medicines,Health,Inflation',
	'metaDesc' => '
-The Business Standard





The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&nbsp;





The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The...',
	'disp' => '<div style="text-align: justify">-The Business Standard</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&nbsp;</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) has issued internal guidelines putting in place norms for verification of actual cost data, provided by companies, through plant visits. &nbsp;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&ldquo;Plant visits to be made for verification of data and collection of additional data, understanding product, process etc, and holding discussions with the officials of the company,&rdquo; the guideline notification said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">As per the norms, the NPPA will look into various aspects such as maintenance of manufacturing unit and machinery, capacity utilization and assessment and research and development activities.</div><div style="text-align: justify">NPPA, which directly controls prices of 74 bulk drugs and formulations containing one or more of these bulk drugs, currently fixes prices of such products based on a cost-plus formula. The regulator seeks actual cost data from companies and gathers information from other sources to calculate the best price.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&ldquo;There are often clashes between data sent by companies and what we gather through other sources. The interpretation of data could also vary. We often arbitrarily accept whatever is lower. So, the effort is to maintain uniformity in approach and avoid subjectivity in interpretation,&rdquo; a senior NPPA official said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Another senior official said, many a times it is found that the cost on capacity enhancement and R&amp;D shown by companies is not valid. &ldquo;There are &nbsp;cases where the company is not using its capacity to the fullest and is increasing cost on maintenance etc. We want to corroborate such information by visiting units, understanding the processes and engaging into discussions with companies,&rdquo; one of the officials said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">While determining prices of products, NPPA would look into technical parameters such as yields, capacity assessment and utilization, maintenance of plant and machinery, cost of raw material, research and development &nbsp;and expansion of manufacturing plants and replacement of machinery.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">In case if a particular unit is manufacturing 90% or more of the total production in the country, the regulator will not visit any other facility to study the same data unless the cost of production at the other facility is lower than that of the major producer, the guidelines said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">However, there are no provisions for penalty for a company submitting wrong details to the regulator. &ldquo;The idea is to monitor and not to punish. The company may not give us wrong information, it is because their interpretation of a data could be different from what we draw out of it. Therefore, refinement of the existing system is necessary,&rdquo; the official said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Experts, however, say that if diligently practiced by the regulator, this may leave little room for drug makers to dodge the system.</div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 17831,
	'title' => 'NPPA to intensify drug price verification',
	'subheading' => '',
	'description' => '<div style="text-align: justify">
-The Business Standard
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
<em>The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&nbsp;</em>
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) has issued internal guidelines putting in place norms for verification of actual cost data, provided by companies, through plant visits. &nbsp;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
&ldquo;Plant visits to be made for verification of data and collection of additional data, understanding product, process etc, and holding discussions with the officials of the company,&rdquo; the guideline notification said.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
As per the norms, the NPPA will look into various aspects such as maintenance of manufacturing unit and machinery, capacity utilization and assessment and research and development activities.
</div>
<div style="text-align: justify">
NPPA, which directly controls prices of 74 bulk drugs and formulations containing one or more of these bulk drugs, currently fixes prices of such products based on a cost-plus formula. The regulator seeks actual cost data from companies and gathers information from other sources to calculate the best price.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
&ldquo;There are often clashes between data sent by companies and what we gather through other sources. The interpretation of data could also vary. We often arbitrarily accept whatever is lower. So, the effort is to maintain uniformity in approach and avoid subjectivity in interpretation,&rdquo; a senior NPPA official said.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
Another senior official said, many a times it is found that the cost on capacity enhancement and R&amp;D shown by companies is not valid. &ldquo;There are &nbsp;cases where the company is not using its capacity to the fullest and is increasing cost on maintenance etc. We want to corroborate such information by visiting units, understanding the processes and engaging into discussions with companies,&rdquo; one of the officials said.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
While determining prices of products, NPPA would look into technical parameters such as yields, capacity assessment and utilization, maintenance of plant and machinery, cost of raw material, research and development &nbsp;and expansion of manufacturing plants and replacement of machinery.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
In case if a particular unit is manufacturing 90% or more of the total production in the country, the regulator will not visit any other facility to study the same data unless the cost of production at the other facility is lower than that of the major producer, the guidelines said.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
However, there are no provisions for penalty for a company submitting wrong details to the regulator. &ldquo;The idea is to monitor and not to punish. The company may not give us wrong information, it is because their interpretation of a data could be different from what we draw out of it. Therefore, refinement of the existing system is necessary,&rdquo; the official said.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
Experts, however, say that if diligently practiced by the regulator, this may leave little room for drug makers to dodge the system.
</div>',
	'credit_writer' => 'The Business Standard, 5 November, 2012, http://www.business-standard.com/india/news/exclusive-nppa-to-intensify-drug-price-verification/194444/on',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'nppa-to-intensify-drug-price-verification-17960',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 17960,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 17831
$metaTitle = 'LATEST NEWS UPDATES | NPPA to intensify drug price verification'
$metaKeywords = 'medicines,Health,Inflation'
$metaDesc = '
-The Business Standard





The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&nbsp;





The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The...'
$disp = '<div style="text-align: justify">-The Business Standard</div><div style="text-align: justify"><br /></div><div style="text-align: justify"><em>The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs&nbsp;</em></div><div style="text-align: justify"><br /></div><div style="text-align: justify">The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) has issued internal guidelines putting in place norms for verification of actual cost data, provided by companies, through plant visits. &nbsp;The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&ldquo;Plant visits to be made for verification of data and collection of additional data, understanding product, process etc, and holding discussions with the officials of the company,&rdquo; the guideline notification said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">As per the norms, the NPPA will look into various aspects such as maintenance of manufacturing unit and machinery, capacity utilization and assessment and research and development activities.</div><div style="text-align: justify">NPPA, which directly controls prices of 74 bulk drugs and formulations containing one or more of these bulk drugs, currently fixes prices of such products based on a cost-plus formula. The regulator seeks actual cost data from companies and gathers information from other sources to calculate the best price.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">&ldquo;There are often clashes between data sent by companies and what we gather through other sources. The interpretation of data could also vary. We often arbitrarily accept whatever is lower. So, the effort is to maintain uniformity in approach and avoid subjectivity in interpretation,&rdquo; a senior NPPA official said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Another senior official said, many a times it is found that the cost on capacity enhancement and R&amp;D shown by companies is not valid. &ldquo;There are &nbsp;cases where the company is not using its capacity to the fullest and is increasing cost on maintenance etc. We want to corroborate such information by visiting units, understanding the processes and engaging into discussions with companies,&rdquo; one of the officials said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">While determining prices of products, NPPA would look into technical parameters such as yields, capacity assessment and utilization, maintenance of plant and machinery, cost of raw material, research and development &nbsp;and expansion of manufacturing plants and replacement of machinery.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">In case if a particular unit is manufacturing 90% or more of the total production in the country, the regulator will not visit any other facility to study the same data unless the cost of production at the other facility is lower than that of the major producer, the guidelines said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">However, there are no provisions for penalty for a company submitting wrong details to the regulator. &ldquo;The idea is to monitor and not to punish. The company may not give us wrong information, it is because their interpretation of a data could be different from what we draw out of it. Therefore, refinement of the existing system is necessary,&rdquo; the official said.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Experts, however, say that if diligently practiced by the regulator, this may leave little room for drug makers to dodge the system.</div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

NPPA to intensify drug price verification

-The Business Standard The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs  The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) has issued internal guidelines putting in place norms for verification of actual cost data, provided by companies, through plant visits.  The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs. “Plant visits to be made for verification of data and collection of additional data, understanding product, process etc, and holding discussions with the officials of the company,” the guideline notification said. As per the norms, the NPPA will look into various aspects such as maintenance of manufacturing unit and machinery, capacity utilization and assessment and research and development activities. NPPA, which directly controls prices of 74 bulk drugs and formulations containing one or more of these bulk drugs, currently fixes prices of such products based on a cost-plus formula. The regulator seeks actual cost data from companies and gathers information from other sources to calculate the best price. “There are often clashes between data sent by companies and what we gather through other sources. The interpretation of data could also vary. We often arbitrarily accept whatever is lower. So, the effort is to maintain uniformity in approach and avoid subjectivity in interpretation,” a senior NPPA official said. Another senior official said, many a times it is found that the cost on capacity enhancement and R&D shown by companies is not valid. “There are  cases where the company is not using its capacity to the fullest and is increasing cost on maintenance etc. We want to corroborate such information by visiting units, understanding the processes and engaging into discussions with companies,” one of the officials said. While determining prices of products, NPPA would look into technical parameters such as yields, capacity assessment and utilization, maintenance of plant and machinery, cost of raw material, research and development  and expansion of manufacturing plants and replacement of machinery. In case if a particular unit is manufacturing 90% or more of the total production in the country, the regulator will not visit any other facility to study the same data unless the cost of production at the other facility is lower than that of the major producer, the guidelines said. However, there are no provisions for penalty for a company submitting wrong details to the regulator. “The idea is to monitor and not to punish. The company may not give us wrong information, it is because their interpretation of a data could be different from what we draw out of it. Therefore, refinement of the existing system is necessary,” the official said. Experts, however, say that if diligently practiced by the regulator, this may leave little room for drug makers to dodge the system.